{"id":"https://openalex.org/W2800436295","doi":"https://doi.org/10.1177/2168479018764660","title":"A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USA","display_name":"A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USA","publication_year":2018,"publication_date":"2018-04-20","ids":{"openalex":"https://openalex.org/W2800436295","doi":"https://doi.org/10.1177/2168479018764660","mag":"2800436295","pmid":"https://pubmed.ncbi.nlm.nih.gov/29714594"},"language":"en","primary_location":{"id":"doi:10.1177/2168479018764660","doi":"https://doi.org/10.1177/2168479018764660","is_oa":false,"landing_page_url":"https://doi.org/10.1177/2168479018764660","pdf_url":null,"source":{"id":"https://openalex.org/S1037458212","display_name":"Therapeutic Innovation & Regulatory Science","issn_l":"2168-4790","issn":["2168-4790","2168-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Innovation & Regulatory Science","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015818525","display_name":"Simon Dalla Torre di Sanguinetto","orcid":"https://orcid.org/0000-0002-0808-4638","observed_orcids":["https://orcid.org/0000-0002-0808-4638"]},"institutions":[{"id":"https://openalex.org/I1325311562","display_name":"Swissmedic","ror":"https://ror.org/03hdjmh87","country_code":"CH","type":"government","lineage":["https://openalex.org/I1325311562"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Simon Dalla Torre Di Sanguinetto","raw_affiliation_strings":["1 Marketing Authorization Sector, Swiss Agency for Therapeutic Products (Swissmedic), Bern, Switzerland","Marketing Authorization Sector, Swiss Agency for Therapeutic Products (Swissmedic), Bern, Switzerland"],"raw_orcid":"https://orcid.org/0000-0002-0808-4638","affiliations":[{"raw_affiliation_string":"1 Marketing Authorization Sector, Swiss Agency for Therapeutic Products (Swissmedic), Bern, Switzerland","institution_ids":["https://openalex.org/I1325311562"]},{"raw_affiliation_string":"Marketing Authorization Sector, Swiss Agency for Therapeutic Products (Swissmedic), Bern, Switzerland","institution_ids":["https://openalex.org/I1325311562"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111579543","display_name":"Esa H. Heinonen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150926","display_name":"Finnish Medicines Agency Fimea","ror":"https://ror.org/04mjpp490","country_code":"FI","type":"government","lineage":["https://openalex.org/I4210150926","https://openalex.org/I4210159665"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Esa Heinonen","raw_affiliation_strings":["2 Division for Assessment of Medicinal Products, Finnish Medicines Agency, Helsinki, Finland","Division for Assessment of Medicinal Products, Finnish Medicines Agency, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2 Division for Assessment of Medicinal Products, Finnish Medicines Agency, Helsinki, Finland","institution_ids":["https://openalex.org/I4210150926"]},{"raw_affiliation_string":"Division for Assessment of Medicinal Products, Finnish Medicines Agency, Helsinki, Finland","institution_ids":["https://openalex.org/I4210150926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050878555","display_name":"Janine Antonov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210146945","display_name":"Unitectra","ror":"https://ror.org/04t5d1438","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I4210146945"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Janine Antonov","raw_affiliation_strings":["3 Unitectra, Technology Transfer Office for the Universities of Basel, Bern and Z\u00fcrich, Bern, Switzerland","Unitectra, Technology Transfer Office for the Universities of Basel, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3 Unitectra, Technology Transfer Office for the Universities of Basel, Bern and Z\u00fcrich, Bern, Switzerland","institution_ids":["https://openalex.org/I4210146945"]},{"raw_affiliation_string":"Unitectra, Technology Transfer Office for the Universities of Basel, Bern, Switzerland","institution_ids":["https://openalex.org/I4210146945"]}]},{"author_position":"last","author":{"id":null,"display_name":"Claus Bolte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1325311562","display_name":"Swissmedic","ror":"https://ror.org/03hdjmh87","country_code":"CH","type":"government","lineage":["https://openalex.org/I1325311562"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Claus Bolte","raw_affiliation_strings":["1 Marketing Authorization Sector, Swiss Agency for Therapeutic Products (Swissmedic), Bern, Switzerland","Marketing Authorization Sector, Swiss Agency for Therapeutic Products (Swissmedic), Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Marketing Authorization Sector, Swiss Agency for Therapeutic Products (Swissmedic), Bern, Switzerland","institution_ids":["https://openalex.org/I1325311562"]},{"raw_affiliation_string":"Marketing Authorization Sector, Swiss Agency for Therapeutic Products (Swissmedic), Bern, Switzerland","institution_ids":["https://openalex.org/I1325311562"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5015818525"],"corresponding_institution_ids":["https://openalex.org/I1325311562"],"apc_list":{"value":4090,"currency":"USD","value_usd":4090},"apc_paid":null,"fwci":0.7205,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.78128031,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"53","issue":"1","first_page":"86","last_page":"94"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.510699987411499,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.510699987411499,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.17810000479221344,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.16380000114440918,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-regulatory-authorities","display_name":"drug regulatory agencies","score":0.6110000014305115},{"id":"https://openalex.org/keywords/swissmedic","display_name":"Swissmedic","score":0.75},{"id":"https://openalex.org/keywords/us-food-and-drug-administration","display_name":"US Food and Drug Administration","score":0.8619999885559082},{"id":"https://openalex.org/keywords/new-chemical-entities","display_name":"new chemical entities","score":0.7900000214576721},{"id":"https://openalex.org/keywords/reasons-for-rejection","display_name":"reasons for rejection","score":0.6930000185966492},{"id":"https://openalex.org/keywords/international-regulatory-comparison","display_name":"international regulatory comparison","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C2777589142","wikidata":"https://www.wikidata.org/wiki/Q6770899","display_name":"Marketing authorization","level":2,"score":0.8027704954147339},{"id":"https://openalex.org/C2778917124","wikidata":"https://www.wikidata.org/wiki/Q7309705","display_name":"Regulatory science","level":2,"score":0.7316864728927612},{"id":"https://openalex.org/C108759981","wikidata":"https://www.wikidata.org/wiki/Q788590","display_name":"Authorization","level":2,"score":0.7187536358833313},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6548248529434204},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.6207718253135681},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6051393151283264},{"id":"https://openalex.org/C2991908516","wikidata":"https://www.wikidata.org/wiki/Q1639780","display_name":"Regulatory authority","level":2,"score":0.5682567358016968},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5099819898605347},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.451376348733902},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.4136587381362915},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3595927357673645},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.3221166729927063},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28751710057258606},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2839643955230713},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.28177952766418457},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.23047921061515808},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.21060550212860107},{"id":"https://openalex.org/C3116431","wikidata":"https://www.wikidata.org/wiki/Q31728","display_name":"Public administration","level":1,"score":0.2092740833759308},{"id":"https://openalex.org/C155202549","wikidata":"https://www.wikidata.org/wiki/Q178803","display_name":"International trade","level":1,"score":0.12274852395057678},{"id":"https://openalex.org/C205649164","wikidata":"https://www.wikidata.org/wiki/Q1071","display_name":"Geography","level":0,"score":0.08590075373649597},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.07792794704437256},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D003657","descriptor_name":"Decision Making","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005062","descriptor_name":"European Union","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013557","descriptor_name":"Switzerland","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D040541","descriptor_name":"Marketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056737","descriptor_name":"Safety-Based Drug Withdrawals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/2168479018764660","doi":"https://doi.org/10.1177/2168479018764660","is_oa":false,"landing_page_url":"https://doi.org/10.1177/2168479018764660","pdf_url":null,"source":{"id":"https://openalex.org/S1037458212","display_name":"Therapeutic Innovation & Regulatory Science","issn_l":"2168-4790","issn":["2168-4790","2168-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Innovation & Regulatory Science","raw_type":"journal-article"},{"id":"pmid:29714594","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29714594","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic innovation & regulatory science","raw_type":"Comparative Study"},{"id":"pmh:oai:www.julkari.fi:10024/137409","doi":null,"is_oa":false,"landing_page_url":"http://www.julkari.fi/handle/10024/137409","pdf_url":null,"source":{"id":"https://openalex.org/S4306402058","display_name":"STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"A1"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W1995486476","https://openalex.org/W2005395875","https://openalex.org/W2474212275"],"related_works":["https://openalex.org/W2474212275","https://openalex.org/W4383301890","https://openalex.org/W2794369493","https://openalex.org/W2132128991","https://openalex.org/W4295828575","https://openalex.org/W2766334088","https://openalex.org/W2961900003","https://openalex.org/W4380854239","https://openalex.org/W4400569218","https://openalex.org/W4387966937"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-05-17T00:00:00"}